Hostname: page-component-745bb68f8f-mzp66 Total loading time: 0 Render date: 2025-02-05T17:35:06.414Z Has data issue: false hasContentIssue false

Why we forget our dreams: Acetylcholine and norepinephrine in wakefulness and REM sleep

Published online by Cambridge University Press:  05 January 2017

Andrea Becchetti
Affiliation:
Department of Biotechnology and Biosciences and Center for Neuroscience of Milan, University of Milano—Bicocca, 20128 Milan, Italyandrea.becchetti@unimib.ithttp://www.btbs.unimib.it
Alida Amadeo
Affiliation:
Department of Biosciences, University of Milano, 20133 Milan, Italyalida.amadeo@unimi.ithttp://www.dbs.unimi.it

Abstract

The ascending fibers releasing norepinephrine and acetylcholine are highly active during wakefulness. In contrast, during rapid-eye-movement sleep, the neocortical tone is sustained mainly by acetylcholine. By comparing the different physiological features of the norepinephrine and acetylcholine systems in the light of the GANE (glutamate amplifies noradrenergic effects) model, we suggest how to interpret some functional differences between waking and rapid-eye-movement sleep.

Type
Open Peer Commentary
Copyright
Copyright © Cambridge University Press 2016 

Regulation of neocortical circuits by ascending regulatory systems involves all of the classic neurotransmitters. Most of the nuclei located in the brainstem, hypothalamus, and basal forebrain not only are reciprocally connected, but also send direct projections to the neocortex (Jones Reference Jones2011; Saper et al. Reference Saper, Fuller, Pedersen, Lu and Scammel2010; Steriade & McCarley Reference Steriade and McCarley2005). The same applies to release by the hypothalamic nuclei of neuropeptides such as orexin/hypocretin in wakefulness and melanin-concentrating hormone (MCH) in rapid-eye-movement (REM) sleep (Aracri et al. Reference Aracri, Banfi, Pasini, Amadeo and Becchetti2015; Jones & Hassani Reference Jones and Hassani2008; Monti et al. Reference Monti, Torterolo and Lagos2013; and references therein). As a first approximation, these bewildering intricacies can be simplified by focusing on the balance in activity between noradrenergic and cholinergic nuclei, which are crucial regulators of arousal and cognition (e.g., Constantinople & Bruno Reference Constantinople and Bruno2011; Schmidt et al. Reference Schmidt, Chew, Bennett, Hammad and Frölich2013). Both project varicose fibers that widely innervate the neocortex, and their global effects are excitatory. During wakefulness, high levels of norepinephrine (NE) and acetylcholine (ACh) cooperate in regulating arousal and cognitive processes. However, although cholinergic transmission is certainly implicated in synaptic plasticity (e.g., Berg Reference Berg2011), the physiological action of NE is thought to be more persistent and more closely related to memory retention and consolidation (e.g., Constantinople & Bruno Reference Constantinople and Bruno2011; McGaugh Reference McGaugh2013; Schmidt et al. Reference Schmidt, Chew, Bennett, Hammad and Frölich2013). The activity of noradrenergic and cholinergic neurons decreases during non-REM (NREM) sleep, whereas in REM sleep, ACh release increases again, whereas NE activity remains low (Datta Reference Datta2010; Lee et al. Reference Lee, Hassani, Alonso and Jones2005; Saper et al. Reference Saper, Fuller, Pedersen, Lu and Scammel2010; Takahashi et al. Reference Takahashi, Kayama, Lin and Sakai2010) (Fig. 1). The fact that neocortex activation in REM sleep is sustained mainly by ACh is a further indication that the cholinergic tone is more directly related to consciousness and executive functions. In fact, the role of REM sleep in memory consolidation remains controversial (Ackermann & Rasch Reference Ackermann and Rasch2014; Rasch & Born Reference Rasch and Born2013).

Figure 1. Cholinergic and noradrenergic activity through the sleep–wake cycle. The scheme provides a qualitative comparison of the activity of the ascending cholinergic and noradrenergic projections, with no pretension of quantitative precision. AU=arbitrary units.

Does the GANE model help suggest possible explanations of the different functional consequences of activating these regulatory systems during brain states? A first central assumption is that, under strong neuronal activation, spillover glutamate stimulates nearby NE varicosities in an N-methyl-D-aspartate (NMDA) receptor-mediated manner. By activating low-affinity β-adrenoreceptors, high NE release would stimulate neuronal excitability, as well as glutamatergic terminals, thus constituting activity “hotspots” that effectively amplify inputs with high priority under phasic arousal. Are such hotspots possible in the cholinergic system? Not much is known about the glutamatergic regulation of ACh release, but evidence does exist of ionotropic glutamate receptors regulating cholinergic terminals in the neocortex (Ghersi et al. Reference Ghersi, Bonfanti, Manzari, Feligioni, Raiteri and Pittaluga2003; Parikh et al. Reference Parikh, Man, Decker and Sarter2008). Hence, it is conceivable that spillover glutamate also stimulates cholinergic fibers. Because it is well known that ACh increases glutamate release (Marchi & Grilli Reference Marchi and Grilli2010), a positive feedback loop could generate local ACh hotspots, analogous to those hypothesized by Mather and colleagues.

A second tenet of the GANE model is that the low-threshold α2-adrenoreceptors, by responding to low NE concentrations, would inhibit glutamate release in pathways implicated in low priority signaling, under aroused conditions. In this respect, the cholinergic system presents several differences compared with the noradrenergic. In particular: (1) cholinergic fibers form both well-differentiated point-to-point synapses and axon varicosities that sustain diffuse ACh release (Dani & Bertrand Reference Dani and Bertrand2007); and (2) ACh activates both metabotropic (muscarinic, mAChRs) and ionotropic (nicotinic, nAChR) receptors. In prefrontal regions, M1 mAChRs are widespread and produce excitatory effects related to working memory through different cellular mechanisms (e.g., McCormick & Prince Reference McCormick and Prince1986; Gulledge et al. Reference Gulledge, Bucci, Zhang, Matsui and Yeh2009; Proulx et al. Reference Proulx, Suri, Heximer, Vaidya and Lambe2014). Their EC50 for ACh is in the low μM range. On the other hand, nAChRs can be divided into two functional classes (Dani & Bertrand Reference Dani and Bertrand2007). Heteromeric nAChRs have high affinity for ACh (with EC50 in the μM range), relatively low permeability to Ca2+ (PCa), and slow desensitization in the presence of agonist. Homomeric nAChRs have high PCa (in the order of the one displayed by NMDA receptors), but low affinity for ACh (EC50 ≈ 200 µM), and quick desensitization kinetics. A striking difference with NE transmission is immediately apparent. The long-term effects on synaptic consolidation are thought to depend on Ca2+ signals. However, within the putative ACh hotspots, the efficacy of high-PCa homomeric receptors would be blunted by quick desensitization. High ACh concentrations would also tend to desensitize heteromeric nAChRs. This would prevent sustained Ca2+ entry through nAChRs as well as by nAChR-dependent activation of glutamate release, and thus of NMDA receptors. Therefore, it seems unlikely that ACh hotspots can produce long-term cellular effects considerably different from those produced by lower ACh concentrations.

In summary, by following up the GANE model reasoning, one is led to conclude that low and high concentrations of NE and ACh produce distinct functional effects on neocortical networks. Low to moderate ACh release sustains global neocortex arousal in both wakefulness and REM sleep. However, in the absence of NE activity (as in REM sleep), cholinergic activity is unable to yield long-term synaptic changes, such as those implicated in memory retention, which would partly explain the well-known difficulty of recalling oneiric activity. Instead, high levels of ACh seem more able to shape the rapid synaptic responses implicated in executive functions, as the quick kinetics of the low-affinity nicotinic ACh receptors would suggest. We believe that deeper functional studies of the interplay between the ascending regulatory systems, led by heuristic models such as GANE, will greatly lead to progress in understanding the physiological basis of cognition.

References

Ackermann, S. & Rasch, B. (2014) Differential effects of non-REM and REM sleep on memory consolidation? Current Neurology and Neuroscience Reports 14:430. doi: 10.1007/s11910-013-0430-8.CrossRefGoogle ScholarPubMed
Aracri, P., Banfi, D., Pasini, M. E., Amadeo, A. & Becchetti, A. (2015) Hypocretin (orexin) regulates glutamate input to fast-spiking interneurons in layer V of the Fr2 region of the murine prefrontal cortex. Cerebral Cortex 25:1330–47. doi: 10.1093/cercor/bht326.CrossRefGoogle Scholar
Berg, D. K. (2011) Timing is everything, even for cholinergic control. Neuron 71:68. doi: 10.1016/j.neuron.2011.06.029.CrossRefGoogle ScholarPubMed
Constantinople, C. M. & Bruno, R. M. (2011) Effects and mechanisms of wakefulness on local cortical networks. Neuron 69(6):1061–68. Available at: http://dx.doi.org/10.1016/j.neuron.2011.02.040.CrossRefGoogle ScholarPubMed
Dani, J. A. & Bertrand, D. (2007) Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annual Review of Pharmacology and Toxicology 47:699729. doi: 10.1146/annurev.pharmtox.47.120505.105214.CrossRefGoogle ScholarPubMed
Datta, S. (2010) Cellular and chemical neuroscience of mammalian sleep. Sleep Medicine 11:431–40. doi: 10.1016/j.sleep.2010.02.002.CrossRefGoogle ScholarPubMed
Ghersi, C., Bonfanti, A., Manzari, B., Feligioni, M., Raiteri, M. & Pittaluga, A. (2003) Pharmacological heterogeneity of release-regulating presynaptic AMPA/kainate receptors in the rat brain: Study with receptor antagonists. Neurochemistry International 42:283–92. doi: 10.1016/S0197-0186(02)00129-8.CrossRefGoogle ScholarPubMed
Gulledge, A. T., Bucci, D. J., Zhang, S. S., Matsui, M. & Yeh, H. H. (2009) M1 receptors mediate cholinergic modulation of excitability in neocortical pyramidal neurons. Journal of Neuroscience 29:9888–902. doi: 10.1523/JNEUROSCI.1366-09.2009.CrossRefGoogle ScholarPubMed
Jones, B. E. (2011) Neurobiology of waking and sleeping. Handbook of Clinical Neurology 98:131–49. doi: 10.1016/B978-0-444-52006-7.00009-5.CrossRefGoogle ScholarPubMed
Jones, B. E. & Hassani, O. K. (2008) The role of Hcrt/Orx and MCH neurons in sleep–wake state regulation. Sleep 36:1769–72. doi: 10.5665/sleep.3188.CrossRefGoogle Scholar
Lee, M. G., Hassani, O. K., Alonso, A. & Jones, B. E. (2005) Cholinergic basal forebrain neurons burst with theta during waking and paradoxical sleep. Journal of Neuroscience 25:4365–69. doi: 10.1523/JNEUROSCI.0178-05.2005.CrossRefGoogle ScholarPubMed
Marchi, M. & Grilli, M. (2010) Presynaptic nicotinic receptors modulating neurotransmitter release in the central nervous system: Functional interactions with other coexisting receptors. Progress in Neurobiology 92:105–11. doi: 10.1016/j.pneurobio.2010.06.004.CrossRefGoogle ScholarPubMed
McCormick, D. A. & Prince, D. A. (1986) Mechanisms of action of acetylcholine in the guinea-pig cerebral cortex in vitro. Journal of Physiology 375:169–94. doi: 10.1113/jphysiol.1986.sp016112.CrossRefGoogle ScholarPubMed
McGaugh, J. L. (2013) Making lasting memories: Remembering the significant. Proceedings of the National Academy of Sciences of the United States of America 110(Suppl. 2):10402–407. doi: 10.1073/pnas.1301209110.CrossRefGoogle ScholarPubMed
Monti, J. M., Torterolo, P. & Lagos, P. (2013) Melanin-concentrating hormone control of sleep–wake behavior. Sleep Medicine Reviews 17:293–98. doi: 10.1016/j.smrv.2012.10.002.CrossRefGoogle ScholarPubMed
Parikh, V., Man, K., Decker, M. W. & Sarter, M. (2008) Glutamatergic contributions to nicotinic acetylcholine receptor agonist-evoked cholinergic transients in the prefrontal cortex. Journal of Neuroscience 28:3769–80. doi: 10.1523/JNEUROSCI.5251-07.2008.CrossRefGoogle ScholarPubMed
Proulx, E., Suri, D., Heximer, S. P., Vaidya, V. A. & Lambe, E. K. (2014) Early stress prevents the potentiation of muscarinic excitation by calcium release in adult prefrontal cortex. Biological Psychiatry 76:315–23. doi: 10.1016/j.biopsych.2013.10.017.CrossRefGoogle ScholarPubMed
Rasch, B. & Born, J. (2013) About sleep's role in memory. Physiological Reviews 93:681766. doi: 10.1152/physrev.00032.2012.CrossRefGoogle ScholarPubMed
Saper, C. B., Fuller, P. M., Pedersen, N. P., Lu, J. & Scammel, T. E. (2010) Sleep state switching. Neuron 68:1023–42. doi: 10.1016/j.neuron.2010.11.032.CrossRefGoogle ScholarPubMed
Schmidt, S. L., Chew, E. Y., Bennett, D. V., Hammad, M. A. & Frölich, F. (2013) Differential effects of cholinergic and noradrenergic neuromodulation on spontaneous cortical network dynamics. Neuropharmacology 72:259–73. doi: 10.1016/j.neuropharm.2013.04.045.CrossRefGoogle ScholarPubMed
Steriade, M. & McCarley, R. W. (2005) Brain control of wakefulness and sleep. Kluwer Academic/Plenum.Google Scholar
Takahashi, K., Kayama, Y., Lin, J. S. & Sakai, K. (2010) Locus coeruleus neuronal activity during the sleep–waking cycle in mice. Neuroscience 169:1116–26. doi: 10.1016/j.neuroscience.2010.06.009.CrossRefGoogle ScholarPubMed
Figure 0

Figure 1. Cholinergic and noradrenergic activity through the sleep–wake cycle. The scheme provides a qualitative comparison of the activity of the ascending cholinergic and noradrenergic projections, with no pretension of quantitative precision. AU=arbitrary units.